Novartis AG
TREATMENT COMPRISING SGLT INHIBITORS

Abstract:

The invention relates to methods for treating, preventing, or ameliorating a liver disease, e.g. NASH, comprising administering to a subject in need thereof a therapeutically effective amount of a SGLT inhibitor, e.g. SGLT 1/2 inhibitor.